“Glucose, urea, and creatinine laboratory tests in people starting antiretroviral therapy with dolutegravir or efavirenz: a cohort study in Belo Horizonte, Brazil” (2022) Research, Society and Development, 11(5), p. e43711528541. doi:10.33448/rsd-v11i5.28541.